Lataa...
T/Tn immunotherapy avoiding immune deviation
Tumor immunotherapy, capable of inducing both cellular and humoral immune responses, is an attractive treatment strategy for cancer. It has been reported that the inactivation of cell-mediated immunity by hyper-activation of humoral immunity—referred to as immune deviation—does not inhibit tumor gro...
Tallennettuna:
| Julkaisussa: | Int J Immunopathol Pharmacol |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
SAGE Publications
2016
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5806843/ https://ncbi.nlm.nih.gov/pubmed/27760846 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/0394632016674018 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|